Article Excerpt: Massive problems require pragmatic, scalable, and evidence-based solutions. Cardiovascular disease (CVD), the world’s leading cause of death, is the epitome of such a problem in need of such a solution. The World Health Organization and American Heart Association have both set goals of reducing CVD mortality 25% by 2025. Achieving the requisite success in CVD prevention, however, will be challenging and will require approaches and tools that (1) have proven clinical benefit, (2) can be scaled to reach a global population, and (3) are affordable.
Full Article: http://tinyurl.com/q484nlj
Article Source: JAMA